|| Checking for direct PDF access through Ovid
To evaluate the efficacy of sacral neuromodulation (SNM) in the subgroup of patients with double anal and urinary incontinence.Eleven consecutive femalespresenting double incontinence were treated by SNM between June 2006 and October 2009.The test, made with a definitive electrode, was positive for 10/11 patients. one patient required a second test as the results from the first test were difficult to interpret. A neuromodulator was definitively implanted in the 11 patients. No patientpresented any complications or infection. Nine patients showed hypotony of the external anal sphincter, and nine hypotony of the internal anal sphincter. Mixed hypotony was found in eight cases. Seven patients had perineal neuropathy, three had rupture of the external anal sphincter of < 1/3 of the circumference of the sphincter and one patient had a sphincter rupture combined with perineal neuropathy. The mean Wexner score was 12.7/20 before implanting and 4.8/20 after implanting.SNM is particularly effective for AI symptoms in patients with double anal and urinary incontinence. An improvement was obtained in all the patients with a decrease in the Wexner score of eight which was maintained over 14 months of follow-up (1-40).